Briquilimab is a monoclonal antibody commercialized by Jasper Therapeutics, with a leading Phase II program in Severe Combined Immune Deficiency (SCID).

A WOMAN nearly DIED after kissing a man at a bar and was rushed to hospital covered in hives. Phoebe Campbell-Harris ...

Ligelizumab is a monoclonal antibody commercialized by Novartis, with a leading Phase III program in Food Allergy.

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of Pittsburgh study ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...

MCLEAN, VA / ACCESSWIRE / December 10, 2024 / Dr. Amir Bajoghli and his colleagues have recently published an insightful case ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...

South Korea’s Celltrion Inc., received new drug submission (NDS) approval from Health Canada for Omlyclo, the biosimilar of ...